Home › Chronic Pain › Indiana › Indianapolis
Chronic Pain clinical trials in Indianapolis, IN
5 studies for Chronic Pain are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
Recruiting
- Indiana University Medical Center, Indianapolis
Options for Pain Management Using Nonpharmacological Strategies
Recruiting
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Equipping Patients Using Interventions for Pain and Depression
Recruiting
- Eskenazi Health Primary Care, Indianapolis
Better Options for Chronic Cancer Pain
RecruitingPhase 4Healthy volunteers welcome
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Stepped-Care Intervention of Music and Imagery to Assess Relief (SCIMITAR) Trial
Recruiting
- Veterans Health Indiana, Indianapolis
About Chronic Pain
Chronic pain lasts longer than three months or the time in which you should have healed. It is not always curable, but treatments can help.
More about Chronic Pain on MedlinePlus
Chronic Pain trials in other cities
- Boston, MA17 studies
- Chicago, IL13 studies
- Baltimore, MD10 studies
- Minneapolis, MN7 studies
- New Haven, CT7 studies
- Houston, TX7 studies
- Mountain View, CA6 studies
- San Francisco, CA6 studies
- Birmingham, AL6 studies
- New York City, NY6 studies
- Washington, DC5 studies
- Durham, NC5 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Breast Cancer20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Lung Cancer16 studies
- Cardiovascular Disease16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.